An interventional study of US guidance and MB staining in Foreign Bodies and Ultrasound, sponsored by Yuxi Su. Completed at 1 site in China. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2021-10-20.
Sponsored by Yuxi Su · Not applicable, Interventional, and Treatment
Soft-tissue foreign bodies (FB) are very commonly observed in pediatric emergency departments. Some are metallic and can be diagnosed easily via X-ray radiography, whereas others are radiolucent and are hence less easily diagnosed. Not all FB can be removed effectively, even via open surgery and C-arm guidance. This deficiency may potentially be addressed through the ultrasound (US) skills instrument, which is increasingly popular and is convenient for use in the operation room. In the current study, we evaluated the efficiency of FB removal with the assistance of US and methylene blue (MB) staining.
Exclusion Criteria:
Ultrasound guidance and methylene blue staining
Procedure: US guidance and MB staining
Open surgery without ultrasound guidance and methylene blue staining
Procedure: US guidance and MB staining
Ultrasound guidance and methylene blue staining
Surgery time
Time from incision made to incision closure
Time frame: Surgery end time
Blood loss
The blood loss of all the surgery time
Time frame: Surgery end time
Plan to share: Undecided — Foreign body removal with the assistance of ultrasound guidance and methylene blue staining in children
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.